AstroNova : Q4 FY26 Earnings Presentation

Published: 2026-04-14 07:14:10 ET ALOT

Published on 04/14/2026 at 07:14 am EDT

Fourth Quarter FY2026 Financial Results

Jorik Ittmann, President and CEO

Tom DeByle, Chief Financial Officer

Printing Technologies for Critical Applications April 13, 2026

Nasdaq: ALOT

Product ID Turnaround Gaining Momentum

Aerospace Delivered Strong Full-Year Performance

Reduced Debt and Strengthened Balance Sheet

Evaluating Strategic Alternatives to Unlock Value

AstroNova 3

Revenue

Q4 FY26 sales up 2.5% Y/Y

Aftermarket revenue remained strong, representing approximately 80% of segment sales

New go-to-market strategy gaining traction with orders up

$2.9M Y/Y

Aerospace sales up 3.3% 2HFY26 vs. 1HFY26

Q4 FY26 sales declined 4.1% Y/Y due primarily reflecting

timing of customer projects

Strong full-year performance - ToughWriter now representing over 80% of flight deck printer shipments

69%

FY26 CONSOLIDATED RECURRING REVENUE

AstroNova 4

($ in millions)

QUARTERS

1H and 2H FY 2026

$73.8

$76.7

$37.4

$37.5

Q4 FY25

Q4 FY26

1H FY26

2H FY26

FULL YEAR

$151.3

$150.5

FY 2025

FY 2026

$46.3

$104.2

$48.92

$102.3

$11.2

$26.3

$11.7

$25.7

$22.8

$51.0

$23.5

$53.2

Gross Profit and Margin

Q4 gross profit margin contracted 256 bps Y/Y to 30.2% reflecting lower volume and mix

Aerospace major royalty obligation will lapse in Q3 FY27 which will provide a $2 million annualized contribution to gross profit beginning in the fourth quarter

($ in millions)

Gross Profit and Margin

QUARTERS

1H v. 2H FY2026

FULL YEAR

$50.7

$47.6

$22.9

$24.8

$12.2

$11.3

Q4 2025

Q4 2026

1HFY26

2HFY26

FY2025

FY2026

Adj. Gross Profit and Margin

QUARTERS

1H v. 2H FY2026

FULL YEAR

$50.9 $49.0

$23.3

$25.7

$12.3

$11.9

Q4 2025

Q4 2026

1HFY26

2HFY26

FY2025

FY2026

31.7%

32.9%

31.5%

33.5%

32.5%

33.6%

30.2%

32.7%

31.0%

32.3%

31.6%

33.5%

Operating Profit and Margin

$0.1

$1.3

Q4 2025

Q4 2026

-$0.1

FY 2025

-33.0%

0.1%

-0.2%

1.7%

-5.7%

Adjusted operating margin expanded 220 bps from first half to second half of FY2026

Higher volume and lower costs supported margin expansion in 2HFY 26

($ in millions)

Operating Profit and Margin

QUARTERS

1H v. 2H FY26

FULL YEAR

$1.2

0.8%

FY 2026

-$12.3

1HFY26

2HFY26

-$8.6

Adj. Operating Profit and Margin

QUARTERS

1H v. 2H FY26

FULL YEAR

$6.6

$5.6

$3.7

$1.4

$1.1

3.0%

$1.9

Q4FY25

Q4FY26

1HFY26

2HFY26

FY25

FY26

3.8%

2.6%

4.8%

3.7%

4.4%

EPS and Adj. EBITDA

EPS and Adjusted EPS1

($ in millions, except per share data)

Net Earnings (Loss) and Adjusted EBITDA/ Adjusted EBITDA Margin1

PY EPS

PY Adj. EPS

CY EPS CY Adj. EPS

PY Net Income

(Loss)

PY Adj. EBITDA

CY Net Earnings (Loss)

CY Adj. EBITDA

AstroNova

Adjusted EPS and adjusted EBITDA and adjusted margin are non-GAAP financial measures. Further information can be found under "Non-GAAP Financial Measures." See also the reconciliation of

GAAP financial measures to non-GAAP financial measures in the tables that accompany this presentation for Adjusted EPS and Adjusted EBITDA. 7

FY 2026

($14.5)

FY 2025

($2.4)

8.4%

8.2%

$12.7

$12.3

$0.06

$(0.15)

$(0.04)

$(2.07)

Q4 FY25

Q4 FY26

$2.8

7.5%

$3.3

8.8%

($1.1)

($15.6)

Q4 FY25

Q4 FY26

$0.32

$0.16

$(0.31)

$(1.93)

FY 2025

FY 2026

Capital Structure and Cash Flow

($ in millions)

1/31/25

1/31/26

Twelve Months Ended

Cash Flow

1/31/25

10/31/25

1/31/26

Capitalization

Net cash provided by operating

activities

$ 11.7 $ 4.8

$ 3.7

$ 11.4

Free cash flow (FCF)(1)

1.2

0.3

Capital expenditure

Strong cash generation in 2H FY2026

$15.9M in liquidity at quarter end

$4.1M in cash and cash equivalents

$11.8M borrowing capacity

Reduced debt by $2.7 million in Q4 and $9.1 million in FY26

Net debt leverage ratio 2.97 vs 4.5 covenant ratio

Fixed charge coverage ratio of 1.43 vs 1.05 covenant req't

Cash and cash

equivalents

$ 4.1

$ 3.6

$ 5.1

Total debt

$ 37.6

$ 40.3

$ 46.7

Shareholders' equity

$ 76.9

$ 75.8

Total capitalization

$ 114.5

$ 117.2

$ 122.5

NOTE: Components may not add to totals due to rounding.

Free cash flow and adjusted EBITDA are non-GAAP financial measures. Further information can be found under "Non-GAAP Financial Measures." See also the reconciliation of GAAP financial measures to non-GAAP financial measures in the tables that accompany this presentation for Adjusted EBITDA and above for the reconciliation of free cash flow. We define Free Cash Flow as net cash from operating activities less capital expenditures.

AstroNova 8

Orders and Backlog

($ in millions)

Product ID Q4FY26 orders grew $2.9 million Y/Y as new go-to-market strategy gains traction; book-to-bill of 104%

Orders

$38.6

$8.7

$26.2

$14.1

$24.5

$34.9

$41.1

$13.4

$22.5

$12.5

$23.4

$13.6

$27.5

$35.9 $35.9

Backlog increased by $1.1 million sequentially

Q4 FY25 Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26

Product ID Aerospace

AEROSPACE

Backlog

Aerospace orders of $13.6M and book-to-bill of 122% reflect sustained OEM demand as aircraft build rates continue to recover

Backlog of $12.0M at year end provides solid

$28.3 $25.5 $25.3

$7.4

$18.0

$9.6

$12.4

$22.0

$25.5

$12.0

$13.5

$8.6

$16.7

$10.2

$18.1

visibility into fiscal 2027

Q4 FY25 Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26

Product ID Aerospace

Plan for Growth

Driving Change - Focused Resources in Sales & Marketing | Strengthening Operational Execution

Driving culture change: honesty, transparency, and accelerated and engaged decision making

Executive leadership deeply engaged with team and customers; leveraging commercial print industry experience and network

Product ID team focused on high-value products with longer sales cycles to drive retention, upgrades, and share expansion

Continuing to identify organizational strengths and weaknesses

Discipline and Strategic Growth

Product ID developing strong pipeline with digital marketing tools for lead generation as well as exhibiting at high-impact industry events, to deepen OEM relationships, expand reach, and enter underpenetrated markets

Filtering leads with disciplined qualification for prioritization, forecast quality and pipeline integrity

Royalty roll-off in FY 2027 ($2M annualized; $2.1M in FY26; $2.5M in FY25), unlocking higher level of profitability for new sales and long-term aftermarket sales

Announced evaluation of strategic alternatives

FY 2027 Outlook

Expecting mid-single digit revenue growth and expanded adjusted EBITDA margin

AstroNova

Conference Call Playback

(412) 317-6671 | passcode: 13759000

Telephone replay available through

Tuesday, April 28, 2026

investors.astronovainc.com/

Deborah K. Pawlowski Phone: 716.843.3908

Email: [email protected]

AstroNova 11

Three Months Ended

Twelve Months Ended

2H Fiscal 2026 and 1H Fiscal 2026

January 31,

2026 2025

2H FY26 1H FY26

Revenue

$ 37,536 $ 37,361

$ 150,515 $ 151,283

$ 76,705 $ 73,810

Gross Profit

11,324

12,227

47,634

50,658

24,76G

22,866

Inventory Step-Up

216

Inventory Provision

365

724

Restructuring Charges

367

337

Product Retrofit Costs

185 -

185

Non-GAAP Gross Profit

$ 11,G03 $ 12,289

$ 48,G71 $ 50,874

$ 25,708 $ 23,264

Gross Profit Margin

30.2%

32.7%

31.6%

33.5%

32.3%

31.0%

Non-GAAP Gross Profit Margin

31.7%

32.9%

32.5%

33.6%

33.5%

31.5%

AstroNova 13

Three Months Ended

Twelve Months Ended

2H Fiscal 2026 and 1H Fiscal 2026

January 31,

2026 2025

2H FY26 1H FY26

Revenue

$ 37,536 $ 37,361

$ 150,515 $ 151,283

$ 76,705 $ 73,810

Operating Income (Loss)

(12,311)

1,206

(8,640)

1,342

$ (137)

MTEX-related Acquisition Expenses

254

311

1,204

311

CFO Transition Costs

432

Inventory Step-Up

216

Inventory Provision

365

724

Restructuring Charges

1,357

110

1,247

Product Retrofit Costs

185

186

Non-Recurring Legal Expenses

258

715

646

Non-Recurring Proxy Costs

210

738

383

355

Goodwill Impairment

- 13,403

2G7 13,403

2G7

Non-GAAP Operating Income

$ 1,124 $ 1,408

$ 5,5G4 $ 6,615

$ 3,688 $ 1,906

Operating Income Margin

0.1%

-33.0%

0.8%

-5.7%

1.7%

-0.2%

Non-GAAP Operating Income Margin

3.0%

3.8%

3.7%

4.4%

4.8%

2.6%

AstroNova 14

Twelve Months Ended

Three Months Ended

January 31,

2026 2025

Net Income (Loss) $ (1,134) $ (15,600)

Interest Expense 8G4 847

Income Tax Expense (Benefit) 346 2,342

EBITDA

$ 1,485 $

(11,145)

Share-Based Compensation

752

219

Depreciation C Amortization 1,37G 1,266

MTEX-related Acquisition Expenses - 259

CFO Transition Costs - (5)

Net Income (Loss)

$ (2,376) $

(14,489)

Interest Expense

3,503

3,210

Income Tax Expense (Benefit)

(160)

2,202

Depreciation C Amortization 4,804 4,780

EBITDA

$ 5,771

$ (4,297)

Share-Based Compensation

2,310

1,378

MTEX-related Acquisition Expenses

311

1,204

CFO Transition Costs

432

Inventory Step-Up

216

Inventory Provision

724

Inventory Step-Up

Restructuring Charges

1,357

Inventory Provision

365

Product Retrofit Costs

185

Restructuring Charges

Non-Recurring Legal Expenses

715

Product Retrofit Costs

185

Non-Recurring Proxy Costs

738

Non-Recurring Legal Expenses

258

Realized Fx

100

Non-Recurring Proxy Costs

210

Other (Income) and Expense

Goodwill Impairment

112

2G7

13,403

Goodwill Impairment

- 13,403

Adjusted EBITDA

$ 12,681

$ 12,336

Adjusted EBITDA

$ 3,306 $ 2,794

Revenue

$ 150,515

$ 151,283

Revenue

$ 37,536 $

37,361

Net Income (Loss) Margin

(1.6)%

(9.6)%

Net Income (Loss) Margin

(3.0)%

(41.8)%

Adjusted EBITDA Margin

8.4%

8.2%

Adjusted EBITDA Margin 8.8% 7.5%

AstroNova 15

Three Months Ended Twelve Months Ended

2026 2025

Revenue

$ 37,536 $ 37,361

$ 150,515 $ 151,283

Net Income (Loss)

$ (1,134)

$ (15,600)

$ (2,376)

$ (14,489)

MTEX-related Acquisition Expenses(1)

197

237

910

CFO Transition Costs, net(1)

(4)

328

Inventory Step-Up(1)

161

Inventory Provision(1)

2G2

565

Restructuring Charges(1)

1,030

Product Retrofit Costs(1)

148

Non-Recurring Legal Expenses(1)

18G

542

Non-Recurring Proxy Costs(1)

160

561

Realized Fx(1)

Other (Income) and Expense(1)

Goodwill Impairment

13,403

2G7

13,403

Tax Provision Valuation Allowance

- 2,373

Non-GAAP Net Income (Loss)

$ (305) $ 419

$ 1,218 $ 2,686

Diluted Earnings (Loss) Per Share

$ (0.15)

$ (2.07)

$ (0.31)

$ (1.93)

MTEX-related Acquisition Expenses(1)

0.03

0.12

CFO Transition Costs, net(1)

(0.00)

0.04

Inventory Step-Up(1)

0.01

0.02

Inventory Provision(1)

0.04

0.07

Restructuring Charges(1)

0.01

0.14

Product Retrofit Costs(1)

0.02

Non-Recurring Legal Expenses(1)

0.02

0.07

Non-Recurring Proxy Costs(1)

0.02

0.07

Realized Fx(1)

0.01

Other (Income) and Expense(1)

0.01

Goodwill Impairment(1)

1.78

0.04

1.76

Tax Provision Valuation Allowance

- 0.31

Non-GAAP Diluted Earnings (Loss) Per Share

$ (0.04) $ 0.06

$ 0.16 $ 0.32

(1) Net of taxes

AstroNova

January 31,

AstroNova

Disclaimer

AstroNova Inc. published this content on April 14, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 14, 2026 at 11:13 UTC.